MedicineBiology

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.

Changping Wu, Yibei Zhu, Jingting Jiang, Jie-Min Zhao, Xue-guang Zhang, N. Xu

2006.5.10ACTA HISTOCHEMICA

DOI: 10.1016/j.acthis.2006.01.003

tlooto Summary

Analysis of programmed death-1 ligand-1 detected by immunohistochemical labeling demonstrated that PD-L1 immunodetection could be used as an independent factor to evaluate the prognosis of gastric carcinoma.

Abstract

Abstract is not available.

Citation format

WU, Changping, et al. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. ACTA HISTOCHEMICA, 2006, 108 1: 19–24.